Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation
- PMID: 34478561
- DOI: 10.1111/jnc.15500
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation
Abstract
Kappa free light chain (KFLC) index, a measure for intrathecal production of free kappa chains, has been increasingly recognized for its diagnostic potential in multiple sclerosis (MS) as a quantitative alternative to IgG oligoclonal bands (OCBs). Our objective was to investigate the sensitivity, specificity, and overall diagnostic accuracy of KFLC index in MS. KFLC index was prospectively determined as part of the diagnostic workup in patients with suspected MS (n = 327) between May 2013 and February 2020. Patients with clinically isolated syndrome (CIS), radiologically isolated syndrome (RIS), and MS had markedly higher KFLC index (44.6, IQR 16-128) compared with subjects with other neuro-inflammatory disorders (ONID) and symptomatic controls (SC) (2.19, IQR 1.68-2.98, p < 0.001). KFLC index had a sensitivity of 0.93 (95% CI 0.88-0.95) and specificity of 0.87 (95% CI 0.8-0.92) to discriminate CIS/RIS/MS from ONID and SC (AUC 0.94, 95% CI 0.91-0.97, p < 0.001). KFLC index and intrathecal fraction (IF) KFLC had similar accuracies to detect MS. Treatment with disease-modifying therapy (DMT) did not influence the level of KFLC index and it was not affected by demographic factors or associated with degenerative or inflammatory biomarkers in cerebrospinal fluid (CSF). KFLC index in MS diagnostics has methodological advantages compared to OCB and is independent to subjective interpretation. Moreover, it is an attractive diagnostic tool since the diagnostic specificity and sensitivity of KFLC index are similar with that of OCBs and KFLCIF and better than for IgG index. We show that KFLC index was influenced neither by DMT nor by demographic factors or other inflammatory or degenerative processes in MS as determined by biomarkers in CSF.
Keywords: Kappa free light chain index; biomarkers; cerebrospinal fluid; diagnosis; multiple sclerosis.
© 2021 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
Similar articles
-
Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.Clin Neurol Neurosurg. 2018 Nov;174:220-229. doi: 10.1016/j.clineuro.2018.09.031. Epub 2018 Sep 25. Clin Neurol Neurosurg. 2018. PMID: 30278299
-
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.Mult Scler. 2016 Apr;22(4):502-10. doi: 10.1177/1352458515594044. Epub 2015 Jul 21. Mult Scler. 2016. PMID: 26199348
-
Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.Neurol Neuroimmunol Neuroinflamm. 2020 Jun 11;7(4):e775. doi: 10.1212/NXI.0000000000000775. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32527760 Free PMC article.
-
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.Cells. 2021 Nov 6;10(11):3056. doi: 10.3390/cells10113056. Cells. 2021. PMID: 34831279 Free PMC article. Review.
-
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.Mult Scler. 2023 Feb;29(2):169-181. doi: 10.1177/13524585221134213. Epub 2022 Dec 1. Mult Scler. 2023. PMID: 36453167 Free PMC article. Review.
Cited by
-
Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination.Clin Chem Lab Med. 2024 Jan 31. doi: 10.1515/cclm-2023-1416. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 38295388 No abstract available.
-
How Early Is Early Multiple Sclerosis?J Clin Med. 2023 Dec 29;13(1):214. doi: 10.3390/jcm13010214. J Clin Med. 2023. PMID: 38202221 Free PMC article. Review.
-
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.Front Immunol. 2023 Oct 25;14:1288169. doi: 10.3389/fimmu.2023.1288169. eCollection 2023. Front Immunol. 2023. PMID: 37954589 Free PMC article.
-
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes.Neurol Neuroimmunol Neuroinflamm. 2023 Aug 28;10(6):e200156. doi: 10.1212/NXI.0000000000200156. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37640543 Free PMC article.
-
Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis.Front Neurol. 2023 Jul 25;14:1223220. doi: 10.3389/fneur.2023.1223220. eCollection 2023. Front Neurol. 2023. PMID: 37560452 Free PMC article.
References
REFERENCES
-
- Andersson, M., Alvarez-Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L. M., Gronning, M., Keir, G., Lamers, K., Link, H., Magalhaes, A., Massaro, A. R., Ohman, S., Reiber, H., Ronnback, L., Schluep, M., … Wurster, U. (1994). Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. Journal of Neurology, Neurosurgery and Psychiatry, 57, 897-902. https://doi.org/10.1136/jnnp.57.8.897.
-
- Arrambide, G., & Tintore, M. (2016). CSF examination still has value in the diagnosis of MS - Commentary. Mult Scler, 22, 997-998. https://doi.org/10.1177/1352458516642033.
-
- Axelsson, M., Mattsson, N., Malmeström, C., Zetterberg, H., & Lycke, J. (2013). The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis. Journal of Neuroimmunology, 264, 100-105. https://doi.org/10.1016/j.jneuroim.2013.09.003.
-
- Blumenfeld-Kan, S., Staun-Ram, E., & Miller, A. (2019). Fingolimod reduces CXCR4-mediated B cell migration and induces regulatory B cells-mediated anti-inflammatory immune repertoire. Multiple Sclerosis and Related Disorders, 34, 29-37. https://doi.org/10.1016/j.msard.2019.06.016.
-
- Cavalla, P., Caropreso, P., Limoncelli, S., Bosa, C., Pasanisi, M. B., Schillaci, V., Alteno, A., Costantini, G., Giordana, M. T., Mengozzi, G., & Vercellino, M. (2020). Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. Journal of Neuroimmunology, 339, 577122. https://doi.org/10.1016/j.jneuroim.2019.577122.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
